139 related articles for article (PubMed ID: 22076510)
1. EU bans embryonic stem cell patents but decision may have limited implications.
Harrison C
Nat Rev Drug Discov; 2011 Nov; 10(12):892-3. PubMed ID: 22076510
[No Abstract] [Full Text] [Related]
2. European ban on stem-cell patents has a silver lining.
Callaway E
Nature; 2011 Oct; 478(7370):441. PubMed ID: 22031415
[No Abstract] [Full Text] [Related]
3. European court bans embryonic stem cell patents.
Moran N
Nat Biotechnol; 2011 Dec; 29(12):1057-9. PubMed ID: 22158341
[No Abstract] [Full Text] [Related]
4. European stem cell patents: taking the moral high road?
Bonetta L
Cell; 2008 Feb; 132(4):514-6. PubMed ID: 18295565
[TBL] [Abstract][Full Text] [Related]
5. Ethical questions to ponder in the European stem cell patent debate.
Curley D; Sharples A
J Biolaw Bus; 2006; 9(3):12-6. PubMed ID: 17152135
[TBL] [Abstract][Full Text] [Related]
6. [Decision of the Court of Justice of the European Union on embryonic stem cell patents. On a legal report on patents: the concept and dignity of the human embryo].
Lacadena JR
Rev Derecho Genoma Hum; 2011; (35):145-80. PubMed ID: 22984753
[TBL] [Abstract][Full Text] [Related]
7. Reaction to the Brüstle decision.
Parker S; England P
Pharm Pat Anal; 2012 Jul; 1(3):233-5. PubMed ID: 24236833
[No Abstract] [Full Text] [Related]
8. Biomedical patents. Wisconsin stem cell patents upheld.
Holden C
Science; 2008 Mar; 319(5870):1602-3. PubMed ID: 18356497
[No Abstract] [Full Text] [Related]
9. Consternation and confusion following EU patent judgment.
Wilmut I
Cell Stem Cell; 2011 Dec; 9(6):498-9. PubMed ID: 22136922
[No Abstract] [Full Text] [Related]
10. Brüstle decision is unhelpful, but not catastrophic.
Lawford Davies J; Denoon A
Cell Stem Cell; 2011 Dec; 9(6):500-1. PubMed ID: 22136924
[No Abstract] [Full Text] [Related]
11. Patents, patients, and public policy: an incomplete intersection at 35 U.S.C. Section 287(c).
Ho CM
Univ Calif Davis Law Rev; 2000; 33(3):601-75. PubMed ID: 16389678
[No Abstract] [Full Text] [Related]
12. Europe. Dismay, confusion greet human stem cell patent ban.
Vogel G
Science; 2011 Oct; 334(6055):441-2. PubMed ID: 22034406
[No Abstract] [Full Text] [Related]
13. Stem cell decision could rewrite rules of patentability.
Katsnelson A
Nat Med; 2010 Jun; 16(6):619. PubMed ID: 20526300
[No Abstract] [Full Text] [Related]
14. Europe halts decisions on stem-cell patents.
Schubert S
Nature; 2005 Jun; 435(7043):720-1. PubMed ID: 15944658
[No Abstract] [Full Text] [Related]
15. [Decision of the Justice Court (Great Chamber) of October 18, 2012 - Oliver Brüstle vs Greenpeace eV].
Rev Derecho Genoma Hum; 2011; (35):241-56. PubMed ID: 22984756
[No Abstract] [Full Text] [Related]
16. Sound and fury after stem cell ruling.
Holmes D
Lancet; 2011 Nov; 378(9803):1617. PubMed ID: 22066138
[No Abstract] [Full Text] [Related]
17. Stem-cell patents confirmed.
Hayden EC
Nature; 2008 Mar; 452(7185):265. PubMed ID: 18354442
[No Abstract] [Full Text] [Related]
18. DNA-based patents: an empirical analysis.
Mills AE; Tereskerz P
Nat Biotechnol; 2008 Sep; 26(9):993-5. PubMed ID: 18779808
[TBL] [Abstract][Full Text] [Related]
19. Europe rules against stem-cell patents.
Abbott A
Nature; 2011 Mar; 471(7338):280. PubMed ID: 21412307
[No Abstract] [Full Text] [Related]
20. Companies balk at California's patent rules for stem cell research.
Keim B
Nat Med; 2007 Jan; 13(1):6. PubMed ID: 17206112
[No Abstract] [Full Text] [Related]
[Next] [New Search]
